Abstracts, IAP'98 8th Meeting of the International Association of Pancreatology July 13–15, 1988 Tokyo, Japan

The content is available as a PDF (11.3 MB).

References

1. Yamada H., Yoshida T., Sakamoto H., Terada M., Sugimura T. Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation. Biochem. Biophys. Res. Commun. 1986;140:167–173. doi: 10.1016/0006-291X(86)91072-7.

2. Sugimura T. Multistep carcinogenesis: A 1992 perspective. Science. 1992;258:603–607. doi: 10.1126/science.1411570.

3. Aoki K., Yoshida T., Matsumoto N., Ide H., Sugimura T., Terada M. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation. Molecular Carcinog. 1997;20:251–258. doi: 10.1002/(SICI)1098-2744(199710)20:2<251::AID-MC12>3.0.CO;2-9.

References

4. Bradley EL. Pancreas. 1996;13:220–223. doi: 10.1097/00006676-199610000-00001.

5. Baron TH, et al. Gastroenterol. 1996;111:755–764. doi: 10.1053/gast.1996.v111.pm8780582.

6. Freeny P. et al. Am. J. Roentgenol (in press).

7. Bradley EL III (personal consecutive senes, 1989–1997).